Answers are grounded in this paper and cite their sources.
The discovery, development, and clinical exploitation of antibiotics with new mechanisms of action is a top priority in the battle against untreatable infectious diseases. Peptidomimetics can successfully control infections caused by multidrug-resistant pathogens. This Perspective discusses findings in a recent Science paper on a member of this class of therapeutic agents that targets bacterial outer-membrane synthesis.
No takes yet. Share an insight, caveat, or question.
Alessandra Bragonzi (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: